Chemours Co Stock Performance
| CC Stock | USD 21.94 0.41 1.90% |
On a scale of 0 to 100, Chemours holds a performance score of 5. The firm shows a Beta (market volatility) of 1.64, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Chemours will likely underperform. Please check Chemours' jensen alpha, maximum drawdown, and the relationship between the coefficient of variation and sortino ratio , to make a quick decision on whether Chemours' price patterns will revert.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Chemours Co are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, Chemours exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.14 | Five Day Return 16.6 | Year To Date Return (30.81) | Ten Year Return 5.47 | All Time Return 5.47 |
Forward Dividend Yield 0.0464 | Payout Ratio 0.7092 | Forward Dividend Rate 1 | Dividend Date 2024-12-16 | Ex Dividend Date 2024-11-15 |
| Chemours dividend paid on 13th of September 2024 | 09/13/2024 |
1 | Acquisition by Alvenia Scarborough of 7903 shares of Chemours at 27.5 subject to Rule 16b-3 | 10/25/2024 |
2 | DuPont de Nemours Earnings Expected to Grow Should You Buy | 10/29/2024 |
3 | Chemours Surges 17 percent On The Recent Q3 Results | 11/04/2024 |
4 | Cabots Q4 Earnings and Revenues Miss Estimates, Rise YY | 11/07/2024 |
5 | Disposition of tradable shares by Picho Diane I. of Chemours at 19.04 subject to Rule 16b-3 | 11/08/2024 |
6 | Charisma Communications Launches Independent Research Agency, CC Insights, to Report on the Industrys Most Pressing Challenges | 11/12/2024 |
7 | The Chemours Company Announces Private Offering of 600,000,000 of Senior Notes Due 2033 | 11/13/2024 |
8 | Los medidores de CC integrados CHX120 de CHINT ofrecen una solucin fiable y precisa | 11/14/2024 |
9 | Acquisition by Cowan Alister of 10200 shares of Chemours at 19.2619 subject to Rule 16b-3 | 11/15/2024 |
10 | What Could a 40 percent Reduction in Data Center Energy Use Mean for the Grid | 11/21/2024 |
| Begin Period Cash Flow | 1.3 B |
Chemours |
Chemours Relative Risk vs. Return Landscape
If you would invest 1,912 in Chemours Co on August 27, 2024 and sell it today you would earn a total of 241.00 from holding Chemours Co or generate 12.6% return on investment over 90 days. Chemours Co is generating 0.2412% of daily returns and assumes 3.4335% volatility on return distribution over the 90 days horizon. Put differently, 30% of stocks are less risky than Chemours on the basis of their historical return distribution, and some 96% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Chemours Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chemours' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chemours Co, and traders can use it to determine the average amount a Chemours' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0703
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.43 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Chemours is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chemours by adding it to a well-diversified portfolio.
Chemours Fundamentals Growth
Chemours Stock prices reflect investors' perceptions of the future prospects and financial health of Chemours, and Chemours fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chemours Stock performance.
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0397 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 6.91 B | ||||
| Shares Outstanding | 149.41 M | ||||
| Price To Earning | 25.49 X | ||||
| Price To Book | 4.90 X | ||||
| Price To Sales | 0.56 X | ||||
| Revenue | 6.03 B | ||||
| Gross Profit | 1.62 B | ||||
| EBITDA | 197 M | ||||
| Net Income | (238 M) | ||||
| Cash And Equivalents | 1.1 B | ||||
| Cash Per Share | 7.73 X | ||||
| Total Debt | 4.3 B | ||||
| Debt To Equity | 2.94 % | ||||
| Current Ratio | 1.82 X | ||||
| Book Value Per Share | 4.40 X | ||||
| Cash Flow From Operations | 556 M | ||||
| Earnings Per Share | 0.50 X | ||||
| Market Capitalization | 3.22 B | ||||
| Total Asset | 8.25 B | ||||
| Retained Earnings | 1.78 B | ||||
| Working Capital | 1.35 B | ||||
| Current Asset | 2.3 B | ||||
| Current Liabilities | 1.47 B | ||||
About Chemours Performance
By analyzing Chemours' fundamental ratios, stakeholders can gain valuable insights into Chemours' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Chemours has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chemours has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 104.53 | 65.67 | |
| Return On Tangible Assets | (0.03) | (0.03) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.03) | (0.03) | |
| Return On Equity | (0.32) | (0.31) |
Things to note about Chemours performance evaluation
Checking the ongoing alerts about Chemours for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chemours help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chemours had very high historical volatility over the last 90 days | |
| The company generated the yearly revenue of 6.03 B. Annual Net Loss to common stockholders was (238 M) with gross profit of 1.62 B. | |
| Chemours has a strong financial position based on the latest SEC filings | |
| Over 83.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: What Could a 40 percent Reduction in Data Center Energy Use Mean for the Grid |
- Analyzing Chemours' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chemours' stock is overvalued or undervalued compared to its peers.
- Examining Chemours' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chemours' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chemours' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chemours' stock. These opinions can provide insight into Chemours' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |